Adalat and Cleocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adalat (nifedipine) and Cleocin (clindamycin phosphate). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Adalat and Cleocin. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is Cleocin?

Cleocin has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 3,940 Cleocin users. Check the latest studies of Cleocin.



On Jul, 29, 2026

27 people who take Adalat and Cleocin together, and have interactions are studied.

Adalat and Cleocin drug interactions.

What are the common drug interactions of Adalat and Cleocin, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Insomnia (sleeplessness)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hepatic enzyme increased
  5. Hepatitis (inflammation of the liver)
  6. Hypertensive crisis
  7. Hypertriglyceridaemia (excess of triglycerides in the blood)
  8. Inflammatory bowel disease
  9. Irritable bowel syndrome
  10. Pancreatitis (inflammation of pancreas)

male:

n/a

What are the common drug interactions of Adalat and Cleocin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Anaemia (lack of blood)
  3. Colitis (inflammation of colon)
  4. Constipation
  5. Depression
  6. Dry skin
  7. Fatigue (feeling of tiredness)
  8. Gastroenteritis (inflammation of stomach and intestine)
  9. Gastrointestinal pain
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Depression
  5. Device related infection
  6. Emotional distress
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
  9. Pain
  10. Renal failure (kidney dysfunction)

40-49:

  1. Renal injury (kidney injury)
  2. Abdominal pain
  3. Abscess jaw (tooth abscess or root abscess)
  4. Actinic keratosis (skin disease due to sun exposure)
  5. Aggression
  6. Alopecia (absence of hair from areas of the body)
  7. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  8. Angina pectoris (chest pain due to ischemia of the heart muscle)
  9. Anxiety
  10. Aortic arteriosclerosis (hardening of the aortic arteries)

50-59:

n/a

60+:

  1. Abscess jaw (tooth abscess or root abscess)
  2. Alopecia (absence of hair from areas of the body)
  3. Cardiomegaly (increased size of heart than normal)
  4. Carotid artery stenosis (narrowing of carotid artery)
  5. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  6. Cataract (clouding of the lens inside the eye)
  7. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  8. Chills (felling of cold)
  9. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  10. Confusional state

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and Cleocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adalat and Cleocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cleocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adalat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cleocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine and clindamycin phosphate (the active ingredients of Adalat and Cleocin, respectively), and Adalat and Cleocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: